Accession Number : ADA181670
Title : Clinical Pharmacology Studies. Phase 1.
Descriptive Note : Annual rept. 1 Jun 85-31 Dec 86,
Corporate Author : JOHNS HOPKINS UNIV BALTIMORE MD DIV OF CLINICAL PHARMACOLOGY
Personal Author(s) : Lietman,Paul S ; Petty,Brent G ; Kornhauser,David M
PDF Url : ADA181670
Report Date : 15 Apr 1987
Pagination or Media Count : 18
Abstract : The scientific work of this year centered around the bioavailability, safety, tolerance, pharmacokinetics and pharmacodynamics of pyridostigmine; and the absorption, safety, tolerance and pharmacokinetics of single doses of WR 6026. These two studies were completed successfully and efficiently, and complete details can be found in the draft Task Reports which have been submitted. These drafts are in the process of review and revision by Division of Experimental Therapeutics personnel prior to publication of final Task Reports.
Descriptors : *CLINICAL MEDICINE, *PHARMACOLOGY, *CHOLINESTERASE INHIBITORS, *ANTIPARASITIC DRUGS, ABSORPTION, PHARMACOKINETICS, PERSONNEL, THERAPY, DOSAGE, ANTIDOTES, DRUGS, TOLERANCES(PHYSIOLOGY), SAFETY, BIOLOGICAL ABSORPTION, LEISHMANIASIS, ORGANOPHOSPHATES, POISONING, ACETYLCHOLINESTERASE
Subject Categories : Pharmacology
Distribution Statement : APPROVED FOR PUBLIC RELEASE